Abstract
Aim:
To investigate the role of inducible nitric oxide synthase (iNOS)-derived nitric oxide (NO) in the cardioprotection of intermittent hypoxia (IH) against ischemia/reperfusion (I/R) injury.
Methods:
Langendorff-perfused isolated rat hearts were used to measure variables of left ventricular function during baseline perfusion, ischemia, and reperfusion period. Nitrate plus nitrite (NOx) content in myocardium was measured using a biochemical method. iNOS mRNA and protein expression in rat left ventricles were detected using reverse transcription polymerase chain reaction (RT-PCR) and Western blot, respectively.
Results:
Myocardial function recovered better in IH rat hearts than in normoxic control hearts. The iNOS-selective inhibitor aminoguanidine (AG) (100 μmol/L) significantly inhibited the protective effects of IH, but had no influence on normoxic rat hearts. The baseline content of NOx in IH hearts was higher than that in normoxic hearts. After 30 min ischemia, the NOx level in normoxic hearts increased compared to the corresponding baseline level, whereas there was no significant change in IH hearts. However, the NOx level in IH hearts was still higher than that of normoxic hearts during ischemia and reperfusion period. AG 100 μmol/L significantly diminished the NOx content in IH and normoxic hearts during ischemia and reperfusion period. The baseline levels of iNOS mRNA and protein in IH hearts were higher than those of normoxic hearts. Compared to the corresponding baseline level, iNOS mRNA and protein levels in normoxic rat hearts increased and those in IH rat hearts decreased after reperfusion. The addition of AG 100 μmol/L significantly decreased iNOS mRNA and protein expression in IH rat hearts after I/R.
Conclusion:
IH upregulated the baseline level of iNOS mRNA and protein expression leading to an increase in NO production, which may play an important role in the cardiac protection of IH against I/R injury.
Similar content being viewed by others
Article PDF
References
Powell FL, Garcia N . Physiological effects of intermittent hypoxia. High Altitude Med Biol 2000; 1: 125–36.
Prabhakar NR . Physiological and genomic consequences of intermittent hypoxia: invited review: oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol 2001; 90: 1986–94.
Meerson FZ, Ustinova EE, Orlova EH . Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia. Clin Cardiol 1987; 10: 783–9.
Asemu G, Papousek F, Ostadal B, Kolar F . Adaptation to high altitude hypoxia protects the rat heart against ischemia-induced arrhythmias. Involvement of mitochondrial KATP channel. J Mol Cell Cardiol 1999; 31: 1821–31.
Zhang Y, Zhong N, Zhu HF, Zhou ZN . Antiarrhythmic and antioxidative effects of intermittent hypoxia exposure on rat myocardium. Acta Physiol Sin 2000; 52: 89–92.
Zhong N, Zhang Y, Zhu HF, Wang JC, Fang QZ, Zhou ZN . Myocardial capillary angiogenesis and coronary flow in ischemia tolerance rat by adaptation to intermittent high altitude hypoxia. Acta Pharmacol Sin 2002; 23: 305–10.
Zhong N, Zhang Y, Fang QZ, Zhou ZN . Intermittent hypoxia exposure-induced heat-shock protein 70 expression increases resistance of rat heart to ischemic injury. Acta Pharmacol Sin 2000; 21: 467–72.
Neckar J, Szarszoi O, Koten L, Papousek F, Ost'adal B, Grover GJ, et al. Effects of mitochondrial KATP modulators on cardioprotection induced by chronic high altitude hypoxia in rats. Cardiovasc Res 2002; 55: 567–75.
Zhu HF, Dong JW, Zhu WZ, Ding HL, Zhou ZN . ATP-dependent potassium channels involved in the cardiac protection induced by intermittent hypoxia against ischemia/reperfusion injury. Life Sci 2003; 73: 1275–87.
Dong JW, Zhu HF, Zhu WZ, Ding HL, Ma TM, Zhou ZN . Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res 2003; 13: 385–91.
Beall CM, Laskowski D, Strohl KP, Soria R, Villena M, Vargas E, et al. Pulmonary nitric oxide in mountain dwellers. Nature 2001; 414: 411–2.
Jones SP, Girod WG, Palazzo AJ, Granger DN, Grisham MB, Jourd'Heuil D, et al. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol 1999; 276: H1567–73.
Weiland U, Haendeler J, Ihling C, Albus U, Scholz W, Ruetten H, et al. Inhibition of endogenous nitric oxide synthase potentiates ischemia- reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway. Cardiovasc Res 2000; 45: 671–8.
Brunner F, Maier R, Andrew P, Wolkart G, Zechner R, Mayer B . Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res 2003; 57: 55–62.
Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 1999; 96: 11507–12.
Bolli R . Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 2001; 33: 1897–918.
Neckar J, Papousek F, Novakova O, Ost'adal B, Kolar F . Cardioprotective effects of chronic hypoxia and ischaemic preconditioning are not additive. Basic Res Cardiol 2002; 97: 161–7.
Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233: 119–25.
Zhang Y, Zhong N, Zhou ZN . Effects of intermittent hypoxia on action potential and contraction on non-ischemic and ischemic rat papillary muscle. Life Sci 2000; 67: 2465–71.
Palmer LA, Semenza GL, Stoler MH, Johns RA . Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol 1998; 274: L212–19.
Jung F, Palmer LA, Zhou N, Johns RA . Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res 2000; 86: 319–25.
Rouet-Benzineb P, Eddahibi S, Raffestin B, Laplace M, Depond S, Adnot S, et al. Induction of cardiac nitric oxide synthase 2 in rats exposed to chronic hypoxia. J Mol Cell Cardiol 1999; 31: 1697–708.
Baker JE, Holman P, Kalyanaraman B, Griffith OW, Pritchard KA Jr . Adaptation to chronic hypoxia confers tolerance to subsequent myocardial ischemia by increased nitric oxide production. Ann N Y Acad Sci 1999; 874: 236–53.
Zweier JL, Wang PH, Kuppusamy P . Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem 1995; 270: 304–7.
Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Inoue M, et al. Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction. Circulation 1996; 93: 356–64.
Zweier JL, Samouilov A, Kuppusamy P . Non-enzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta 1999; 1411: 250–62.
Zingarelli B, Hake PW, Yang Z, O'Connor M, Denenberg A, Wong HR . Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damage. FASEB J 2002; 16: 327–42.
Xie Q, Nathan C . The high-output nitric oxide pathway: role and regulation. J Leukoc Biol 1994; 56: 576–82.
Yasmin W, Strynadka KD, Schulz R . Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 1997; 33: 422–32.
Wang P, Zweier JL . Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 1996; 271: 29223–30.
Kelly RA, Balligand JL, Smith TW . Nitric oxide and cardiac function. Circ Res 1996; 79: 363–80.
Brown GC . Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999; 1411: 351–69.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No 30393130) and the Science and Technology Committee of Shanghai Municipality (No 02JC14038).
Rights and permissions
About this article
Cite this article
Ding, Hl., Zhu, Hf., Dong, Jw. et al. Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury. Acta Pharmacol Sin 26, 315–322 (2005). https://doi.org/10.1111/j.1745-7254.2005.00046.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00046.x
Keywords
This article is cited by
-
Alleviation of calcium hydroxide nanoparticles induced genotoxicity and gastritis by coadministration of calcium titanate and yttrium oxide nanoparticles in mice
Scientific Reports (2023)
-
Alleviation of Cadmium Chloride–Induced Acute Genotoxicity, Mitochondrial DNA Disruption, and ROS Generation by Chocolate Coadministration in Mice Liver and Kidney Tissues
Biological Trace Element Research (2022)
-
Changes in nitric oxide synthase levels are associated with impaired cardiac function and tolerance to ischemia-reperfusion injury in male rats with transient congenital hypothyroidism
Naunyn-Schmiedeberg's Archives of Pharmacology (2020)
-
Chronic Intermittent Hypobaric Hypoxia Ameliorates Renal Vascular Hypertension Through Up-regulating NOS in Nucleus Tractus Solitarii
Neuroscience Bulletin (2019)
-
Role of inducible nitric oxide synthase in myocardial ischemia-reperfusion injury in sleep-deprived rats
Sleep and Breathing (2018)